LIXTE BIOTECHNOLOGY HOLDINGS, INC. 8-K

What Happened

• Lixte Biotechnology Holdings, Inc. (ticker: LIXT) filed an 8-K reporting that it closed the merger with Nomad Transportable Power Systems, Inc. The merger became effective July 1, 2026, and Nomad became a wholly owned subsidiary. The company also changed its name to Nomad Power Solutions, Inc., effective July 3, 2026.
• At closing the company issued 2,992,041 newly designated common shares (Exchange Common Shares) and 50,366.07 shares of newly designated Series D Convertible Preferred Stock (Exchange Preferred Shares). The Series D preferred has an original issue price of $1,000 per preferred share and is convertible at $1.00 per common share (i.e., each preferred can convert into 1,000 common shares), making the issued preferred convertible into up to approximately 50,366,070 common shares. The Series D preferred are non‑voting until stockholder approval to allow conversion is obtained.

Key Details

• Merger effective: July 1, 2026; Name change effective: July 3, 2026; press release issued July 2, 2026.
• Shares issued: 2,992,041 Exchange Common Shares and 50,366.07 Exchange Preferred Shares (convertible at $1.00 per share).
• Stockholder meeting: Board set record date July 6, 2026; meeting to be held on or about September 4, 2026 to vote on conversion approval, increase in authorized shares, and director elections. Proxy materials will be filed and mailed in advance.
• Registration & protections: Company agreed to file resale registration(s) for the Exchange Common Shares and the common stock underlying the Series D within specified timelines tied to stockholder approval, audit completion or time-based triggers; certain company stockholders entered into support agreements committing to vote in favor of the merger-related approvals. Unaccredited Nomad holders receive cash in lieu of stock based on a 60‑day VWAP of $5.57.

Why It Matters

• Ownership and dilution: The issuance of ~50.4K Series D preferred (convertible into ~50.4M common shares at $1 conversion) represents a material potential increase in outstanding common shares if converted — conversion is subject to stockholder approval. Investors should watch the upcoming stockholder meeting (record date July 6, meeting ~Sept 4) for votes on conversion and any increase in authorized shares.
• Share liquidity & resale: The company agreed to register resale of the exchanged securities under specified timelines, which affects when holders can freely trade the issued shares. Unaccredited Nomad holders were cashed out based on the $5.57 VWAP, which removes some small‑holder dilution.
• Corporate governance: The board approved bylaw changes removing the classified board provision (declassifying directors) and appointed John Travaglini to the board effective July 1, 2026. These governance changes and the Support Agreements reduce uncertainty around obtaining the approvals needed to convert the preferred and complete post‑closing steps.

Investors should review the filed Merger Agreement, Certificate of Designations, Registration Rights Agreement and proxy materials (to be filed) for full terms and timing.